Cargando…

Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis

Background: Possible influences of statin therapy on the risk of cardiovascular events, cancer, and all-cause mortality in people living with HIV (PLWH) remain unclear. We performed a meta-analysis to systematically evaluate the efficacy of statin in PLWH. Methods: Relevant cohort studies were retri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanping, Wang, Zhandi, Xia, Haimei, Zhang, Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606632/ https://www.ncbi.nlm.nih.gov/pubmed/34820402 http://dx.doi.org/10.3389/fmed.2021.769740

Ejemplares similares

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis
por: Uthman, Olalekan A., et al.
Publicado: (2018)

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy
por: Zeng, Rui-Xiang, et al.
Publicado: (2022)

Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020)

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients
por: Inaguma, Daijo, et al.
Publicado: (2019)

The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia
por: Wu, Huanyu, et al.
Publicado: (2022)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Trajectories of physical health-related quality of life and the risk of incident cardiovascular disease events and all-cause mortality in older people()
por: Phyo, Aung Zaw Zaw, et al.
Publicado: (2022)

Statin use and incident cardiovascular events in renal transplant recipients
por: Anderson, Josephine L. C., et al.
Publicado: (2021)

Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with diabetes
por: Wu, Li-Da, et al.
Publicado: (2023)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic
por: Papaioannu Borjesson, Rebecka, et al.
Publicado: (2023)

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021)

Native T1 is predictive of cardiovascular death/heart failure events and all-cause mortality irrespective of the patient’s volume status
por: Treiber, Julia, et al.
Publicado: (2023)

Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat
por: Wang, Hong-Fei, et al.
Publicado: (2022)

Malignancy and all-cause mortality; incidence in adolescents and young adults living with perinatally acquired HIV
por: Chhabra, Srishti, et al.
Publicado: (2020)

Statin‐related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all‐cause mortality
por: Insani, Widya N., et al.
Publicado: (2022)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Association of Total Bilirubin With All-Cause and Cardiovascular Mortality in the General Population
por: Chen, Ziwei, et al.
Publicado: (2021)

Statins and All‐Cause Mortality in Patients Undergoing Hemodialysis
por: Jung, Jaehun, et al.
Publicado: (2020)

Community‐Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV
por: Zifodya, Jerry S., et al.
Publicado: (2020)

The association of central and extremity circumference with all-cause mortality and cardiovascular mortality: a cohort study
por: Liu, Jiajun, et al.
Publicado: (2023)

One-hour plasma glucose as a long-term predictor of cardiovascular events and all-cause mortality in a Chinese older male population without diabetes: A 20-year retrospective and prospective study
por: Rong, Lingjun, et al.
Publicado: (2022)

Associations Between Healthy Lifestyle Trajectories and the Incidence of Cardiovascular Disease With All-Cause Mortality: A Large, Prospective, Chinese Cohort Study
por: Ding, Xiong, et al.
Publicado: (2021)

Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease
por: Kim, Moon-Hyun, et al.
Publicado: (2022)

Significantly Increased Risk of All-Cause Mortality Among Type 2 Diabetes Patients Living Alone
por: Fu, Liyao, et al.
Publicado: (2022)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality
por: de Rezende, Leandro Fórnias Machado, et al.
Publicado: (2018)

Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2022)

Acute Lower Respiratory Tract Infection Increased the Risk of Cardiovascular Events and All-Cause Mortality in Elderly Patients With Stable Coronary Artery Disease
por: Zhao, Xiaoqian, et al.
Publicado: (2021)

Triglyceride-glucose (TyG) index is a predictor of arterial stiffness, incidence of diabetes, cardiovascular disease, and all-cause and cardiovascular mortality: A longitudinal two-cohort analysis
por: Muhammad, Iram Faqir, et al.
Publicado: (2023)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

Serum IL8 is not associated with cardiovascular events but with all-cause mortality
por: Moreno Velásquez, Ilais, et al.
Publicado: (2019)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
por: Mehrabani-Zeinabad, Kamran, et al.
Publicado: (2023)

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
por: Qiu, Mei, et al.
Publicado: (2021)

Association of nighttime physical activity with all-cause and cardiovascular mortality: Results from the NHANES
por: Yi, Jiayi, et al.
Publicado: (2022)

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023)

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
por: Guan, Lihua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_djut1eom0k5ohm7l0r2c9lbqbb